HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Abstract
The autosomal dominant multiple endocrine neoplasia type 2 syndromes (MEN 2) comprise three clinically distinct entities, MEN 2A, familial medullary thyroid carcinoma and MEN 2B, which share a common clinical feature: medullary thyroid carcinoma (MTC). MEN 2B is considered to have the most aggressive form of MTC. Therefore, early detection of MEN 2B in order to prevent potentially lethal MTC is important. More than 95% of all MEN 2B cases are caused by germline mutation at codon 918 (M918T) in exon 16 of the RET proto-oncogene. In this study, we demonstrate the presence of germline codon 883 mutation (A883F) in 2 of 3 unrelated MEN 2B cases without codon 918 mutation. Our data demonstrate a novel etiologic event which may have roles in predisposition to MEN 2B when present in the germline and in the pathogenesis of sporadic MTC when somatic.
AuthorsO Gimm, D J Marsh, S D Andrew, A Frilling, P L Dahia, L M Mulligan, J D Zajac, B G Robinson, C Eng
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 82 Issue 11 Pg. 3902-4 (Nov 1997) ISSN: 0021-972X [Print] United States
PMID9360560 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Drosophila Proteins
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ret
  • Receptor Protein-Tyrosine Kinases
  • Ret protein, Drosophila
  • Alanine
Topics
  • Alanine (genetics)
  • Codon
  • Drosophila Proteins
  • Exons
  • Germ-Line Mutation
  • Humans
  • Multiple Endocrine Neoplasia Type 2b (genetics)
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins c-ret
  • Receptor Protein-Tyrosine Kinases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: